MedTrace Logo

Stroke Rehabilitation Program Based on a Powered Lower Extremity Exoskeleton in Chile

NCT04228224 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-07-16

No results posted yet for this study

Summary

This research will study the effects of a rehabilitation program assisted by a powered lower extremity exoskeleton in patients after stroke. It will compare clinical and biomechanical features of patients at baseline and after intervention. Additionally, it will also examine the use of a brain-computer-interface (BCI) to command movements on the powered lower limb exoskeleton. The findings will be used to improve understanding human-robot interaction, to improve the design of the robotic devices and to improve rehabilitation services.

Conditions

Interventions

DEVICE

Robot-assisted training with a lower extremity powered exoskeleton (H3 Exoskeleton, Spain)

The H3 is a powered lower extremity exoskeleton with actuated at hips, knees and ankles joints. A novel control software has been design and implemented in this device, which allows selective joint movement and recording of data from each rehabilitation session.

BEHAVIORAL

Conventional gait rehabilitation

Conventional gait rehabilitation consist in walking and other applicable lower limb exercises performed by participants with assistance of a physical therapist.

Sponsors & Collaborators

  • Corporación de Rehabilitación Club de Leones Cruz del Sur

    lead OTHER

Principal Investigators

  • Asterio H Andrade Gallardo, MSc. · Corporación de Rehabilitacion Club de Leones Cruz del Sur

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2020-01-31
Completion
2020-03-31

Countries

  • Chile

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04228224 on ClinicalTrials.gov